Jenny Y Mei, Sabrina Alexander, Hector E Muñoz, Aisling Murphy
{"title":"Risk factors for emergency department visits and readmissions for postpartum hypertension.","authors":"Jenny Y Mei, Sabrina Alexander, Hector E Muñoz, Aisling Murphy","doi":"10.1080/14767058.2025.2451662","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Postpartum hypertension accounts for 15 to 20% of postpartum Emergency Department (ED) visits and readmissions in the United States. Postpartum readmission is a quality metric and target of quality improvement as it indicates poor control of hypertension and can portend increased morbidity. We aim to evaluate risk factors for postpartum ED visits and readmissions for hypertension.</p><p><strong>Methods: </strong>This was a retrospective cohort study of all birthing patients with peripartum hypertension at a single tertiary care center over a 5-year period (2017-2022). Inclusion criteria were age 18 years or above, existing diagnosis of chronic hypertension or hypertensive disease of pregnancy diagnosed during the intrapartum or postpartum course, and both delivery and ED visit or readmission at the study institution. Maternal baseline and intrapartum characteristics were chart abstracted. Primary outcome was ED visit or readmission (EDR) for postpartum hypertension. Patients who had EDR within 42 days of delivery were compared to those who underwent routine outpatient surveillance. For all analyses, <i>p</i> values were two-way, and the level of statistical significance was set at <i>p</i> < 0.05.</p><p><strong>Results: </strong>Of 16,162 patients who gave birth during the study period, 2403 (14.9%) patients met the definition of peripartum hypertension. 218 (9.1%) presented to the ED or were readmitted for hypertension. Risk factors for EDR were as follows: maternal age ≥40 years (22.9% vs 15.3%, <i>p</i> = 0.003), prenatal aspirin use (6.9% vs 3.9%, <i>p</i> = 0.039), cesarean delivery (42.7% vs 35.8%, <i>p</i> = 0.044), chronic hypertension (37.2% vs 31.6%, <i>p</i> = 0.029), preeclampsia with severe features (32.6% vs 15.6%, <i>p</i> < 0.001), postpartum hemorrhage (22.9% vs 12.0%, <i>p</i> < 0.001), and intrapartum need for intravenous anti-hypertensives (23.9% vs 3.3%, <i>p</i> < 0.001). Factors at discharge that increased risk of EDR included prescription of anti-hypertensives at discharge (27.5% vs 8.6%, <i>p</i> < 0.001) and having >50% elevated blood pressures within the 24 h prior to discharge (16.5% vs 11.9%, <i>p</i> = 0.046). In a multivariable logistic regression controlling for prenatal aspirin use, mode of delivery, postpartum hemorrhage, and chorioamnionitis, a higher risk of EDR remained for maternal age ≥40 years (aOR, 1.56; 95% confidence interval (CI), 1.11-2.20; <i>p</i> = 0.011), PO anti-hypertensives at discharge (aOR, 4.05; 95% CI, 2.86-5.73; <i>p</i> < 0.001), preeclampsia with severe features (aOR, 2.50; 95% CI, 1.83-3.42; <i>p</i> < 0.001), and history of IV anti-hypertensive exposure (aOR, 9.30; 95% CI, 6.20-13.95; <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>Maternal age of 40 years and above, chronic hypertension, preeclampsia with severe features, prescription of anti-hypertensives on discharge, and elevated blood pressures leading up to discharge are associated with postpartum ED visits or readmissions for hypertension. Risk factor identification can aid in the development of predictive tools to determine high risk groups and interventions to reduce ED visits and readmissions.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2451662"},"PeriodicalIF":1.7000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Maternal-Fetal & Neonatal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14767058.2025.2451662","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/19 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Postpartum hypertension accounts for 15 to 20% of postpartum Emergency Department (ED) visits and readmissions in the United States. Postpartum readmission is a quality metric and target of quality improvement as it indicates poor control of hypertension and can portend increased morbidity. We aim to evaluate risk factors for postpartum ED visits and readmissions for hypertension.
Methods: This was a retrospective cohort study of all birthing patients with peripartum hypertension at a single tertiary care center over a 5-year period (2017-2022). Inclusion criteria were age 18 years or above, existing diagnosis of chronic hypertension or hypertensive disease of pregnancy diagnosed during the intrapartum or postpartum course, and both delivery and ED visit or readmission at the study institution. Maternal baseline and intrapartum characteristics were chart abstracted. Primary outcome was ED visit or readmission (EDR) for postpartum hypertension. Patients who had EDR within 42 days of delivery were compared to those who underwent routine outpatient surveillance. For all analyses, p values were two-way, and the level of statistical significance was set at p < 0.05.
Results: Of 16,162 patients who gave birth during the study period, 2403 (14.9%) patients met the definition of peripartum hypertension. 218 (9.1%) presented to the ED or were readmitted for hypertension. Risk factors for EDR were as follows: maternal age ≥40 years (22.9% vs 15.3%, p = 0.003), prenatal aspirin use (6.9% vs 3.9%, p = 0.039), cesarean delivery (42.7% vs 35.8%, p = 0.044), chronic hypertension (37.2% vs 31.6%, p = 0.029), preeclampsia with severe features (32.6% vs 15.6%, p < 0.001), postpartum hemorrhage (22.9% vs 12.0%, p < 0.001), and intrapartum need for intravenous anti-hypertensives (23.9% vs 3.3%, p < 0.001). Factors at discharge that increased risk of EDR included prescription of anti-hypertensives at discharge (27.5% vs 8.6%, p < 0.001) and having >50% elevated blood pressures within the 24 h prior to discharge (16.5% vs 11.9%, p = 0.046). In a multivariable logistic regression controlling for prenatal aspirin use, mode of delivery, postpartum hemorrhage, and chorioamnionitis, a higher risk of EDR remained for maternal age ≥40 years (aOR, 1.56; 95% confidence interval (CI), 1.11-2.20; p = 0.011), PO anti-hypertensives at discharge (aOR, 4.05; 95% CI, 2.86-5.73; p < 0.001), preeclampsia with severe features (aOR, 2.50; 95% CI, 1.83-3.42; p < 0.001), and history of IV anti-hypertensive exposure (aOR, 9.30; 95% CI, 6.20-13.95; p < 0.001).
Conclusions: Maternal age of 40 years and above, chronic hypertension, preeclampsia with severe features, prescription of anti-hypertensives on discharge, and elevated blood pressures leading up to discharge are associated with postpartum ED visits or readmissions for hypertension. Risk factor identification can aid in the development of predictive tools to determine high risk groups and interventions to reduce ED visits and readmissions.
目的:在美国,产后高血压占产后急诊科(ED)就诊和再入院的15%至20%。产后再入院是一个质量指标和质量改善的目标,因为它表明高血压控制不良,并可能预示着发病率的增加。我们的目的是评估产后ED就诊和高血压再入院的危险因素。方法:这是一项回顾性队列研究,在一个三级保健中心进行了5年(2017-2022年)的所有围产期高血压分娩患者。纳入标准为年龄18岁及以上,在产时或产后诊断为慢性高血压或妊娠期高血压疾病,在研究机构分娩和ED就诊或再入院。将产妇基线及产时特征抽象化。主要结局为产后高血压患者的ED就诊或再入院(EDR)。将分娩42天内发生EDR的患者与接受常规门诊监测的患者进行比较。结果:在研究期间分娩的16162例患者中,2403例(14.9%)患者符合围产期高血压的定义。218例(9.1%)因高血压就诊或再次入院。发生EDR的危险因素如下:产妇年龄≥40岁(22.9% vs 15.3%, p = 0.003)、产前使用阿司匹林(6.9% vs 3.9%, p = 0.039)、剖宫产(42.7% vs 35.8%, p = 0.044)、慢性高血压(37.2% vs 31.6%, p = 0.029)、伴有严重特征的子痫前期(32.6% vs 15.6%, p = 0.029)、出院前24 h内血压升高50% (16.5% vs 11.9%, p = 0.046)。在控制产前阿司匹林使用、分娩方式、产后出血和绒毛膜羊膜炎的多变量logistic回归中,年龄≥40岁的产妇发生EDR的风险仍然较高(aOR, 1.56;95%置信区间(CI), 1.11-2.20;p = 0.011),出院时PO抗高血压(aOR, 4.05;95% ci, 2.86-5.73;结论:产妇年龄40岁及以上、慢性高血压、重度子痫前期、出院时服用降压药、出院前血压升高与产后ED就诊或高血压再入院相关。风险因素识别可以帮助开发预测工具,以确定高风险人群和干预措施,以减少急诊科就诊和再入院。
期刊介绍:
The official journal of The European Association of Perinatal Medicine, The Federation of Asia and Oceania Perinatal Societies and The International Society of Perinatal Obstetricians. The journal publishes a wide range of peer-reviewed research on the obstetric, medical, genetic, mental health and surgical complications of pregnancy and their effects on the mother, fetus and neonate. Research on audit, evaluation and clinical care in maternal-fetal and perinatal medicine is also featured.